Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
| Buyback Record Date | |
| Buyback Open Date | March 21, 2023 |
| Buyback Closing Date | May 12, 2023 |
| Issue Size (Amount) | ₹210.00 Crores |
| Buyback Price | ₹700 per Share |
Natco Pharma Limited is coming up with BuyBack of the face value of ₹2 each, for an amount of ₹[.] Crores ('Base Issue Size') with an option to retain oversubscription up to ₹210.00 Crores.
Incorporated in 1981, Natco Pharma Limited is a vertically integrated and R&D-focused pharmaceutical company. the entity is engaged in developing, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).
The issue opens on Mar 21, 2023 and closes for subscription on Sep 20, 2023. The shares of the company to be list at BSE, NSE.
The public issue of Natco Pharma Limited opens on Mar 21, 2023 and closes for subscription on Sep 20, 2023.
The Natco Pharma Buyback 2023 are proposed to list at BSE, NSE.
This page provides Buyback news of Natco Pharma Buyback 2023. The Natco Pharma Buyback 2023 watch offers the latest Buyback issue news and keep you updated with the latest Buyback news in India.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
